• Technology Partnering Opportunity

In addition to seeking potential partners for our internal pipeline we are currently seeking partnerships and collaborations for the following platform technologies:

  • ADC Linker – Proof-of-concept research collaborations utilizing partner’s antibodies.

    We have developed a proprietary antibody-drug conjugate (ADC) linker called CL2A, designed for targeted delivery of SN-38. (More)

  • DOCK-AND-LOCK® – Proof-of-concept research collaborations utilizing partner’s targets and/or antibodies.

    DOCK-AND-LOCK®, or DNL®, is a proprietary platform technology for creating a wide variety of multivalent antibodies of increasing complexity. (More)

  • F-18 labeling – Non-exclusive licenses are available.

    We have invented a novel and facile method of labeling peptides with fluorine-18 (F-18) for use in imaging of diseases using position-emission tomography. (More)